What is Medifast 5-Year ROIIC %?
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Medifast's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was 65.45%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medifast's 5-Year ROIIC % or its related term are showing as below:
MED's 5-Year ROIIC % is ranked better than
89.36% of 94 companies
in the Personal Services industry
Industry Median: 3.01 vs MED: 65.45
Medifast 5-Year ROIIC % Historical Data
The historical data trend for Medifast's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Medifast 5-Year ROIIC % Chart
| Medifast Annual Data | ||||||||||||||||||||
| Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
| 5-Year ROIIC % | Get a 7-Day Free Trial | 1,230.37 | 368.85 | 129.08 | 136.20 | 65.45 | ||||||||||||||
| Medifast Quarterly Data | ||||||||||||||||||||
| Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
| 5-Year ROIIC % | Get a 7-Day Free Trial | - | - | - | 65.45 | - | ||||||||||||||
Competitive Comparison of Medifast's 5-Year ROIIC %
For the Personal Services subindustry, Medifast's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast's 5-Year ROIIC % Distribution in the Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medifast's 5-Year ROIIC % falls into.
Medifast 5-Year ROIIC % Calculation
Medifast's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
| 5-Year ROIIC % | = | 5-Year Incremental Net Operating Profit After Taxes (NOPAT)** | / | 5-Year Incremental Invested Capital** |
| = | ( 97.5697038 (Dec. 2023) - 54.6150204 (Dec. 2018) ) | / | ( 92.338 (Dec. 2023) - 26.707 (Dec. 2018) ) | |
| = | 42.9546834 | / | 65.631 | |
| = | 65.45%*** |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medifast(NYSE:MED) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medifast 5-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Medifast's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Medifast (Medifast) Business Description
Industry
GURUFOCUS.COM »STOCK LIST »Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » 5-Year ROIIC %
Comparable Companies
WW CSV MUGH YYGH EJH RGS EVTK TRNR IVP PDRO ROL SCI HRB BFAM TSX:BYD FTDR MCW HKSE:01448 LSE:CVSG OHEL:MUSTI
Traded in Other Exchanges
MED:Mexico MDF:Germany MDF:Germany
Address
100 International Drive, Baltimore, MD, USA, 21202
Website
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
| Jeffrey J Brown | director | 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612 |
| Andrea B Thomas | director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Michael A. ho*r | director | MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202 |
| Scott Schlackman | director | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Hallquist Constance J. | director | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Elizabeth A. Geary | director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Daniel R Chard | director, officer: Chief Executive Officer | NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601 |
| Jonathan Barrett Mackenzie | officer: VP, Finance & CAO | 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Kevin G Byrnes | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Michael C Macdonald | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| James P. Maloney | officer: Chief Financial Officer | 415 HOLIDAY DRIVE, PITTSBURGH PA 15220 |
| Ming Xian | director | MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202 |
| Carl E Sassano | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Joseph P Kelleman | officer: (Interim) CFO | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Timothy G Robinson | officer: Chief Financial Officer | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
Medifast (Medifast) Headlines
From GuruFocus
Medifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021*
By PRNewswire PRNewswire • 11-02-2022
OPTAVIA ACTIVE� Now Available
By PRNewswire • 09-13-2023
Medifast Opens Product Innovation Center as Company Anticipates Continued Rapid Growth
By PRNewswire PRNewswire • 07-09-2022
Medifast Announces Second Quarter 2023 Financial Results
By PRNewswire • 08-07-2023
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022
By PRNewswire PRNewswire • 02-07-2023
Medifast Announces First Quarter 2023 Financial Results
By PRNewswire PRNewswire • 05-01-2023
Medifast Announces Quarterly Dividend
By PRNewswire PRNewswire • 03-17-2023
By PRNewswire • 10-05-2023
Over 17,000 Registered for Flagship OPTAVIA Event Following Year of Rapid Growth
By PRNewswire PRNewswire • 07-25-2022
Medifast Expands into $30B Sports Nutrition Category with OPTAVIA ACTIVE�
By PRNewswire • 07-27-2023
